Sir,
Mitochondrial β oxidation is the principal pathway by which energy is obtained from fatty acids. Defects in this pathway are associated with hypoketotic hypoglycaemia, hepatic steatosis, rhabdomyolysis, cardiomyopathy, hypocarnitaemia, and abnormal urinary metabolites. Long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) deficiency disrupts this pathway and was first described in 1989.1, 2, 3, 4 Treatment is with a low-fat high-carbohydrate diet, carnitine and docozahexanoic acid (DHA) supplementation. Pigmentary retinopathy has been associated with this abnormality.5, 6, 7, 8, 9 We report such a case with follow-up over a 10 year period.
Case report
A 5-year-old emmetropic girl with a history of LCHAD deficiency was referred to the ophthalmology department for evaluation. She was on vitamin supplementation, carnitine and a low-fat high–carbohydrate diet. At first presentation, her visual acuity was recorded at 6/6 in each eye. Fundal examination was documented as showing a bilateral pigmentary retinopathy. During the first 6 years of follow-up her visual acuity remained at a similar level. At the age of 11 a myopic prescription was prescribed, right −0.75 DS/−1.0@180, left −0.5 DS/−0.75@180, visual acuity remaining 6/6 in each eye. At the age of 15 the patient complained of visual deterioration. Visual acuity in the right eye had deteriorated to 6/24 while the left eye retained 6/6 vision. The degree of myopia had increased to right −4.0 DS/−1.75@10, left −3.25 DS/−1.0@170. Ophthalmoscopy showed extensive posterior pole atrophy (Figure 1) in each eye with an ‘island’ of retinal pigment epithelium retained in the left eye (Figure 1b). A small hyper-pigmented spot was also noted at the fovea of each eye. The periphery of each eye showed granular RPE changes. Retinal vasculature was of normal appearance. Anterior segments were normal.
Electrophysiology has been carried out at intervals over a 10-year period. The electroretinogram has remained within normal limits, however, the amplitude of the scotopic a-wave and photopic b-wave have fallen to the lower limit of normal range. The electro-oculogram has been normal with an Arden index of over 210%.
Comment
The ocular findings associated with this rare metabolic disorder include developmental cataracts, progressive myopia, visual field defects, and colour vision abnormalities.8 Tyni et al8 classified the chorioretinopathy into four stages. At stage 1, the fundus appears normal to diffusely hypo pigmented. Stage 2, pigment clumping in the RPE gives rise to pigmentary changes. At stage 3, the granular fundus pigmentation disappears centrifugally with concomitant atrophy of the choroid and the posterior pole, leaving bare sclera.
At stage 4, the central island of the remaining choroids and photoreceptors is lost and posterior pole becomes atrophic and devoid of RPE. At the periphery choroidal vessels and RPE remain relatively normal.
As with all β oxidation defects treatment is aimed at ensuring sufficient caloric intake during periods of metabolic stress and fasting. Owing to secondary carnitine deficiency carnitine supplementation is prescribed to all patients with this condition. A low-fat high-carbohydrate diet is also regarded as beneficial. However, one of the most beneficial forms of the treatment is to avoid fasting.
We describe the striking fundal findings and progression of this retinal dystrophy in a patient with a 10-year follow-up period. One noticeable additional feature seen in this patient's fundal findings was the hyperpigmented spot at the centre of the macula in the right and the left eye. ERG findings show only subtle changes in implicit times and amplitudes. These do not appear to mirror visual acuity but may be representative of the gradual but ultimately progressive nature of this condition. Progressive myopia has been noted to coincide with the development of the staphylomatous like posterior pole changes and may be a better indicator of disease progression in this dystrophy.
In conclusion, LCHAD deficiency is associated with a progressive retinal dystrophy, which maybe slowed by careful dietary management but ultimately over time progression appears to occur.
References
Hagenfeldt L, von Dobeln U, Holme E, Alm J, Brandberg G, Enocksson E et al. 3-hydroxydicarboxylic aciduria- a fatty acid oxidation defect with severe prognosis. J Paediatr 1990; 116: 387–392.
Poll-The B, Bonnefont J, Ogier H, Charpentier C, Pelet A, Le Fur J et al. Familial hypoketotic hypoglycaemia associated with peripheral neuropathy, pigmentary retinopathy and C6-C14 hydroxydicarboxylic aciduria. A new defect in fatty acid oxidation?. J Inherit Metab Dis 1988; 11 (Suppl 2): 183–185.
Pollit RJ, Losty H, Westwood A . 3-hydroxydicarboxylic aciduria of possible diagnostic significance. J Inherit Metab Dis 1987; 10: 266.
Kelly R, Morton D . 3-hydroxyoctanoic aciduria: identification of a new organic acid in the urine of a patient with non-ketotic hypoglycaemia. Clin Chim Acta 1988; 175: 19–26.
Schrijver-Weiling I, van Rens GH, Wittebol-Post D, Smeitink JAM, Jager JP, Klerk HBC . Retinal dystrophy in long chain 3-hydroxy-acyl-coA dehydrogenase deficiency. Br J Ophthalmol 1997; 81 (4): 291–294.
Lawler DP, Kalina RE . Pigmentary retinopathy in long chain 3-hydroxy-acyl-coenzyme A dehydrogenase deficiency. Am J Ophthalmol 1997; 123 (6): 846–848.
Puri P, Chan J . Stable pigmentary retinopathy in a child with 3-hydroxyacyl-CoA dehydrogenase deficiency. Eye 2000; 14: 659–661.
Tyni T, Kivela T, Lappi M, Summanen P, Nikoskelainen E, Pihko H . Ophthalmological findings in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation. A new type of chorioretinopathy. Opthalmology 1998; 105 (5): 810–824.
Tyni T, Pikho H . Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Acta Paediatr 1999; 88: 237–245.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no proprietary interest in the material presented
Rights and permissions
About this article
Cite this article
McGimpsey, S., Williams, M. & Mulholland, D. Ten year follow up of pigmentary retinopathy associated with 3-hydroxyacyl-CoA dehydrogenase deficiency. Eye 20, 1074–1075 (2006). https://doi.org/10.1038/sj.eye.6702105
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.eye.6702105